Exagen (XGN)CEO sold ~$41K

~$41K

Approx. value · 11K sh @ $3.61

703K

Holds after · shares reported

Traded

Feb 24, 2026

Filed

Feb 26, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 11, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
2. Feb 24, 2026 · this disclosureInsiderCEO sold ~$41K of XGN shares in the open market

What came next

1. Feb 24, 2026InsiderCFO sold ~$5.7K of XGN shares in the open market
2. Mar 3, 2026InsiderCEO sold ~$57K of XGN shares in the open market
3. Mar 10, 2026Company filing · Form 8-K · ResultsReported its results
4. Apr 17, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 17, 2026, Ana Hooker notified the Board of Directors (the “Board”) of Exagen Inc. (the “Company”) of her decision to resign as member of the Board, including all committees thereof, effective April 17, 2026 ("Effective Time").”
5. May 11, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Exagen

For Exagen, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its XGN page.

Other recent filings by John Aballi, President and CEO

• SEC Form 4 at Exagen (XGN)Mar 4, 2026
• SEC Form 4 at Exagen (XGN)Oct 20, 2025
• SEC Form 4 at Exagen (XGN)Nov 18, 2024

The full history of John Aballi, President and CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Exagen

• SEC Form 4Sep 2, 2026
• SEC Form 4Mar 4, 2026
• SEC Form 4Feb 26, 2026
• SEC Form 4Oct 20, 2025
• SEC Form 4Sep 4, 2025
• SEC Form 4Mar 27, 2025

Everything OQRO holds on this company is on its XGN page.